Brian Baumann
Physician · Helios Specialty Healthcare
Credentials: · · · · ·
History
- 2026–Present
- 2012–2013
Preliminary or Transitional Year
Research
Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization
PLoS ONE · 2013 · 164 citations
JAMA Oncology · 2020 · First of 13 authors · 151 citations
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022
Journal of the National Comprehensive Cancer Network · 2021 · 123 citations

36 papers

33 papers

28 papers · 8 as a resident

25 papers · 6 as a resident
- RB
25 papers · 21 as a resident

15 papers

15 papers · 14 as a resident

12 papers · 12 as a resident
Clinical trials
- 2025–2032
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
- 2024–2028
SpaceIT Hydrogel System for Perirectal Spacing
Principal investigator · Active not recruiting
Boston Scientific Corporation
- 2023–2024
Principal investigator · Terminated
Varian, a Siemens Healthineers Company



